Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
165,547,872
-
Total 13F shares
-
28,622,740
-
Share change
-
+2,184,623
-
Total reported value
-
$814,197,912
-
Price per share
-
$28.45
-
Number of holders
-
136
-
Value change
-
+$73,379,749
-
Number of buys
-
77
-
Number of sells
-
56
Institutional Holders of CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX) as of Q1 2018
As of 31 Mar 2018 CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX) had 136 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 28,622,740 shares of stock of the company.
Largest 10 holders included FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), MILLENNIUM MANAGEMENT LLC, and Invesco Ltd..
This table shows 136 institutional shareholders of the security as of 31 Mar 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.